|
Model Number PXB35-06-17-080 |
Device Problems
Malposition of Device (2616); Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/17/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician was attempting to use a visi pro balloon expandable stent along with a non-medtronic 6fr sheath during procedure to treat to treat a severely calcified lesion in the proximal renal artery.The vessel diameter and lesion length were 6mm and 15mm respectively.No embolic protection was used.The lesion was pre dilated.The device did not pass through a previously deployed stent. it was reported that during delivery to/at lesion site, stent dislodgement occurred. physician states he had sheath close to renal artery tried to pass then looked up and stent was on wire then off and slide down to hypogastric artery.Stent settled in hypogastric artery which was meant for renal artery.The dislodged stent was not removed and no intervention was performed. stent was in hypogastric and then physician closed in groin.
|
|
Manufacturer Narrative
|
Additional information: the stent was left inside the patient's aorta instead of the renal artery it was intended to be in.Multiple techniques and attempts were made to retrieve the device that ultimately were unsuccessful.A vascular surgeon was able to move the loose stent from the aorta and ultimately left it in the left hypogastric artery but was unable to remove it from the patient.The dislodged stent was not removed. physician states he had sheath close to renal artery tried to pass then looked up and stent was on wire then off and slide down to hypogastric artery.No further injury reported.A3 initial reporter provided.Medwatch rpt# (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|